Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Bellati

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Journal of Cellular and Molecular Medicine|September 29, 2009
Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppressionChiara Napoletano, Filippo Bellati, Rachele Landi, et al.
European Journal of Immunology|April 26, 2012
Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activationChiara Napoletano, Ilaria G Zizzari, Aurelia Rughetti, et al.
Transfusion|August 12, 2015
Thrombotic thrombocytopenic purpura during pregnancy versus imitator of preeclampsiaMaria Luisa Gasparri, Filippo Bellati, Roberto Brunelli, et al.
Geburtshilfe Und Frauenheilkunde|March 11, 2021
Biological Impact of Unilateral Oophorectomy: Does the Number of Ovaries Really Matter?Maria Luisa Gasparri, Ilary Ruscito, Elena Ioana Braicu, et al.
Anticancer Research|November 1, 2016
Immunological and Clinical Impact of Cancer Stem Cells in Vulvar Cancer: Role of CD133/CD24/ABCG2-Expressing CellsChiara Napoletano, Filippo Bellati, Ilary Ruscito, et al.
Gynecologic Oncology|May 14, 2018
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysisIlary Ruscito, Silvia Darb-Esfahani, Hagen Kulbe, et al.
International Journal of Oncology|February 20, 2016
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trialMorena Antonilli, Hassan Rahimi, Valeria Visconti, et al.
Cancer Immunology Research|April 30, 2014
Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processingAurelia Rughetti, Hassan Rahimi, Francesca Belleudi, et al.
International Journal of Oncology|January 19, 2008
RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patientsChiara Napoletano, Federica Taurino, Mauro Biffoni, et al.
Journal of Translational Medicine|February 14, 2026
The immunological fitness of NSCLC patients drives the response to anti-PD1-based immunotherapy regardless of ageLucrezia Tuosto, Alain Gelibter, Lidia Strigari, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Journal of Cellular and Molecular Medicine|September 29, 2009
Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppressionChiara Napoletano, Filippo Bellati, Rachele Landi, et al.
European Journal of Immunology|April 26, 2012
Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activationChiara Napoletano, Ilaria G Zizzari, Aurelia Rughetti, et al.
Transfusion|August 12, 2015
Thrombotic thrombocytopenic purpura during pregnancy versus imitator of preeclampsiaMaria Luisa Gasparri, Filippo Bellati, Roberto Brunelli, et al.
Geburtshilfe Und Frauenheilkunde|March 11, 2021
Biological Impact of Unilateral Oophorectomy: Does the Number of Ovaries Really Matter?Maria Luisa Gasparri, Ilary Ruscito, Elena Ioana Braicu, et al.
Anticancer Research|November 1, 2016
Immunological and Clinical Impact of Cancer Stem Cells in Vulvar Cancer: Role of CD133/CD24/ABCG2-Expressing CellsChiara Napoletano, Filippo Bellati, Ilary Ruscito, et al.
Gynecologic Oncology|May 14, 2018
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysisIlary Ruscito, Silvia Darb-Esfahani, Hagen Kulbe, et al.
International Journal of Oncology|February 20, 2016
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trialMorena Antonilli, Hassan Rahimi, Valeria Visconti, et al.
Cancer Immunology Research|April 30, 2014
Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processingAurelia Rughetti, Hassan Rahimi, Francesca Belleudi, et al.
International Journal of Oncology|January 19, 2008
RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patientsChiara Napoletano, Federica Taurino, Mauro Biffoni, et al.
Journal of Translational Medicine|February 14, 2026
The immunological fitness of NSCLC patients drives the response to anti-PD1-based immunotherapy regardless of ageLucrezia Tuosto, Alain Gelibter, Lidia Strigari, et al.
Pageof 11